Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Recruiting 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 8Breast 8Head & Neck 7Gynecologic 6Genitourinary 6Gastrointestinal 5Thoracic 4Other solid neoplasm 4Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Other 1Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Adenocarcinoma Of Esophagus 2Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pancreatic Adenocarcinoma 1Melanoma 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1Adenocarcinoma 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Metformin × Gastrointestinal × 1 year × Clear all
NCT04114136 2026-04-24

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

University of Pittsburgh

Phase 2 Recruiting
72 enrolled
DermatologicGastrointestinalHead & Neck

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

NCT02437656 2026-03-31

METCAP

Centre Oscar Lambret

Phase 2 Completed
60 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02336087 2026-02-04

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

City of Hope Medical Center

Phase 1 Active not recruiting
21 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma

NCT03889795 2025-10-20

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

University of Toledo

Phase 1 Active not recruiting
15 enrolled
GastrointestinalOther solid neoplasm

Advanced Pancreatic Cancer

NCT06687876 2025-07-10

MEMENTO

Amsterdam UMC, location VUmc

Phase 2 Recruiting
14 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡